<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li KP</submitter><funding>National Natural Science Foundation of China</funding><pagination>6617586</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7955866</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2021</volume><pubmed_abstract>The progressive increase of metabolic diseases underscores the necessity for developing effective therapies. Although we found Tian-Huang formula (THF) could alleviate metabolic disorders, the underlying mechanism remains to be fully understood. In the present study, firstly, male Sprague-Dawley rats were fed with high-fat diet plus high-fructose drink (HFF, the diet is about 60% of calories from fat and the drink is 12.5% fructose solution) for 14 weeks to induce hepatosteatosis and glucose intolerance and then treated with THF (200 mg/kg) for 4 weeks. Then, metabolomics analysis was performed with rat liver samples and following the clues illustrated by Ingenuity Pathway Analysis (IPA) with the metabolomics discoveries, RT-qPCR and Western blotting were carried out to validate the putati</pubmed_abstract><journal>Evidence-based complementary and alternative medicine : eCAM</journal><pubmed_title>Tian-Huang Formula, a Traditional Chinese Medicinal Prescription, Improves Hepatosteatosis and Glucose Intolerance Targeting AKT-SREBP Nexus in Diet-Induced Obese Rats.</pubmed_title><pmcid>PMC7955866</pmcid><funding_grant_id>81530102</funding_grant_id><funding_grant_id>2019B030302005</funding_grant_id><funding_grant_id>2020KTSCX058</funding_grant_id><pubmed_authors>Guo J</pubmed_authors><pubmed_authors>Li KP</pubmed_authors><pubmed_authors>Rong XL</pubmed_authors><pubmed_authors>Turnbull JE</pubmed_authors><pubmed_authors>Yuan M</pubmed_authors><pubmed_authors>Zhang CM</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tian-Huang Formula, a Traditional Chinese Medicinal Prescription, Improves Hepatosteatosis and Glucose Intolerance Targeting AKT-SREBP Nexus in Diet-Induced Obese Rats.</name><description>The progressive increase of metabolic diseases underscores the necessity for developing effective therapies. Although we found Tian-Huang formula (THF) could alleviate metabolic disorders, the underlying mechanism remains to be fully understood. In the present study, firstly, male Sprague-Dawley rats were fed with high-fat diet plus high-fructose drink (HFF, the diet is about 60% of calories from fat and the drink is 12.5% fructose solution) for 14 weeks to induce hepatosteatosis and glucose intolerance and then treated with THF (200 mg/kg) for 4 weeks. Then, metabolomics analysis was performed with rat liver samples and following the clues illustrated by Ingenuity Pathway Analysis (IPA) with the metabolomics discoveries, RT-qPCR and Western blotting were carried out to validate the putati</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-18T13:54:24.646Z</modification><creation>2025-04-06T23:45:17.471Z</creation></dates><accession>S-EPMC7955866</accession><cross_references><pubmed>33763145</pubmed><doi>10.1155/2021/6617586</doi></cross_references></HashMap>